APO Research
Talk to an analyst

APO RESEARCH · REPORT

Peptide Therapeutics

Peptides are short chains of amino acid monomers linked by peptide (amide) bonds, the covalent chemical bonds formed when the carboxyl group of one amino acid reacts with the amino group of another.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Peptides are short chains of amino acid monomers linked by peptide (amide) bonds, the covalent chemical bonds formed when the carboxyl group of one amino acid reacts with the amino group of another.

Selected research

Market Structure

Global Peptide Therapeutics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

25 December 2025191 pages

Choose your research edition.

Industry ResearchPeptide Therapeutics Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Peptide Therapeutics Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Peptide Therapeutics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Peptide Therapeutics Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Peptide Therapeutics Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

Peptides are short chains of amino acid monomers linked by peptide (amide) bonds, the covalent chemical bonds formed when the carboxyl group of one amino acid reacts with the amino group of another.

Global Peptide Therapeutics key players include Sanofi, Novo Nordisk, Takeda, Eli Lilly, Ipsen, etc. Global top five manufacturers hold a share about 65%.

North America is the largest market, with a share about 55%, followed by Europe and Asia-Pacific, both have a share about 40 percent.

Read the full market overview

In terms of product, Injection is the largest segment, with a share about 70%. And in terms of application, the largest application is Cancer, followed by Central Nervous System.

Report Includes

This report provides an overview of the global Peptide Therapeutics market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Peptide Therapeutics and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Peptide Therapeutics revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Peptide Therapeutics market size, projected growth trends, production technologies, key applications, and end-use industries.

Peptide Therapeutics Segment by Company

Sanofi

Teva

Novo Nordisk

Takeda

Eli Lilly

AstraZeneca

Novartis

AbbVie

Ipsen

Ferring

Merck

The Medicines

J & J

Peptide Therapeutics Segment by Type

Injection

Oral

Other

Peptide Therapeutics Segment by Application

Cancer

Metabolic Disorders

Central Nervous System

Other

Peptide Therapeutics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Peptide Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Peptide Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Peptide Therapeutics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Peptide Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Peptide Therapeutics industry.

Chapter 3: Detailed analysis of Peptide Therapeutics companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Peptide Therapeuticsrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Peptide Therapeutics Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Injection Table 3. Key Players of Oral Table 4. Key Players of Other Table 4. Global Peptide Therapeutics Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Cancer Table 6. Key Players of Metabolic Disorders Table 7. Key Players of Central Nervous System Table 8. Key Players of Other Table 9. Global Peptide Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 10. Global Peptide Therapeutics Market Size by Region (2021-2026) & (US$ Million) Table 11. Global Peptide Therapeutics Market Share by Region (2021-2026) Table 12. Global Peptide Therapeutics Market Size by Region (2027-2032) & (US$ Million) Table 13. Global Peptide Therapeutics Market Share by Region (2027-2032) Table 14. Peptide Therapeutics Industry Trends Table 15. Peptide Therapeutics Industry Drivers Table 16. Peptide Therapeutics Industry Opportunities and Challenges Table 17. Peptide Therapeutics Industry Restraints Table 18. Global Peptide Therapeutics Revenue by Company (US$ Million) & (2021-2026) Table 19. Global Peptide Therapeutics Revenue Market Share by Company (2021-2026) Table 20. Global Peptide Therapeutics Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 21. Global Peptide Therapeutics Key Company Head Office and Area Served Table 22. Global Peptide Therapeutics Company, Product Type & Application Table 23. Global Peptide Therapeutics Company Establishment Date Table 24. Global Company Market Concentration Ratio (CR5 and HHI) Table 25. Global Peptide Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 26. Global Peptide Therapeutics Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Peptide Therapeutics Market Size by Type (2021-2026) & (US$ Million) Table 28. Global Peptide Therapeutics Market Size by Type (2027-2032) & (US$ Million) Table 29. Global Peptide Therapeutics Revenue Market Share by Type (2021-2026) Table 30. Global Peptide Therapeutics Revenue Market Share by Type (2027-2032) Table 31. Global Peptide Therapeutics Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Peptide Therapeutics Market Size by Application (2021-2026) & (US$ Million) Table 33. Global Peptide Therapeutics Market Size by Application (2027-2032) & (US$ Million) Table 34. Global Peptide Therapeutics Revenue Market Share by Application (2021-2026) Table 35. Global Peptide Therapeutics Revenue Market Share by Application (2027-2032) Table 36. Sanofi Company Information Table 37. Sanofi Business Overview Table 38. Sanofi Peptide Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Sanofi Peptide Therapeutics Product Portfolio Table 40. Sanofi Recent Development Table 41. Teva Company Information Table 42. Teva Business Overview Table 43. Teva Peptide Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Teva Peptide Therapeutics Product Portfolio Table 45. Teva Recent Development Table 46. Novo Nordisk Company Information Table 47. Novo Nordisk Business Overview Table 48. Novo Nordisk Peptide Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Novo Nordisk Peptide Therapeutics Product Portfolio Table 50. Novo Nordisk Recent Development Table 51. Takeda Company Information Table 52. Takeda Business Overview Table 53. Takeda Peptide Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Takeda Peptide Therapeutics Product Portfolio Table 55. Takeda Recent Development Table 56. Eli Lilly Company Information Table 57. Eli Lilly Business Overview Table 58. Eli Lilly Peptide Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Eli Lilly Peptide Therapeutics Product Portfolio Table 60. Eli Lilly Recent Development Table 61. AstraZeneca Company Information Table 62. AstraZeneca Business Overview Table 63. AstraZeneca Peptide Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. AstraZeneca Peptide Therapeutics Product Portfolio Table 65. AstraZeneca Recent Development Table 66. Novartis Company Information Table 67. Novartis Business Overview Table 68. Novartis Peptide Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Novartis Peptide Therapeutics Product Portfolio Table 70. Novartis Recent Development Table 71. AbbVie Company Information Table 72. AbbVie Business Overview Table 73. AbbVie Peptide Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. AbbVie Peptide Therapeutics Product Portfolio Table 75. AbbVie Recent Development Table 76. Ipsen Company Information Table 77. Ipsen Business Overview Table 78. Ipsen Peptide Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Ipsen Peptide Therapeutics Product Portfolio Table 80. Ipsen Recent Development Table 81. Ferring Company Information Table 82. Ferring Business Overview Table 83. Ferring Peptide Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Ferring Peptide Therapeutics Product Portfolio Table 85. Ferring Recent Development Table 86. Merck Company Information Table 87. Merck Business Overview Table 88. Merck Peptide Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 89. Merck Peptide Therapeutics Product Portfolio Table 90. Merck Recent Development Table 91. The Medicines Company Information Table 92. The Medicines Business Overview Table 93. The Medicines Peptide Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 94. The Medicines Peptide Therapeutics Product Portfolio Table 95. The Medicines Recent Development Table 96. J & J Company Information Table 97. J & J Business Overview Table 98. J & J Peptide Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 99. J & J Peptide Therapeutics Product Portfolio Table 100. J & J Recent Development Table 101. North America Peptide Therapeutics Market Size by Type (2021-2026) & (US$ Million) Table 102. North America Peptide Therapeutics Market Size by Type (2027-2032) & (US$ Million) Table 103. North America Peptide Therapeutics Market Size by Application (2021-2026) & (US$ Million) Table 104. North America Peptide Therapeutics Market Size by Application (2027-2032) & (US$ Million) Table 105. North America Peptide Therapeutics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 106. North America Peptide Therapeutics Market Size by Country (2021-2026) Table 107. North America Peptide Therapeutics Market Size by Country (2027-2032) Table 108. Europe Peptide Therapeutics Market Size by Type (2021-2026) & (US$ Million) Table 109. Europe Peptide Therapeutics Market Size by Type (2027-2032) & (US$ Million) Table 110. Europe Peptide Therapeutics Market Size by Application (2021-2026) & (US$ Million) Table 111. Europe Peptide Therapeutics Market Size by Application (2027-2032) & (US$ Million) Table 112. Europe Peptide Therapeutics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 113. Europe Peptide Therapeutics Market Size by Country (2021-2026) Table 114. Europe Peptide Therapeutics Market Size by Country (2027-2032) Table 115. China Peptide Therapeutics Market Size by Type (2021-2026) & (US$ Million) Table 116. China Peptide Therapeutics Market Size by Type (2027-2032) & (US$ Million) Table 117. China Peptide Therapeutics Market Size by Application (2021-2026) & (US$ Million) Table 118. China Peptide Therapeutics Market Size by Application (2027-2032) & (US$ Million) Table 119. Asia Peptide Therapeutics Market Size by Type (2021-2026) & (US$ Million) Table 120. Asia Peptide Therapeutics Market Size by Type (2027-2032) & (US$ Million) Table 121. Asia Peptide Therapeutics Market Size by Application (2021-2026) & (US$ Million) Table 122. Asia Peptide Therapeutics Market Size by Application (2027-2032) & (US$ Million) Table 123. Asia Peptide Therapeutics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 124. Asia Peptide Therapeutics Market Size by Country (2021-2026) Table 125. Asia Peptide Therapeutics Market Size by Country (2027-2032) Table 126. South America, Middle East & Africa Peptide Therapeutics Market Size by Type (2021-2026) & (US$ Million) Table 127. South America, Middle East & Africa Peptide Therapeutics Market Size by Type (2027-2032) & (US$ Million) Table 128. South America, Middle East & Africa Peptide Therapeutics Market Size by Application (2021-2026) & (US$ Million) Table 129. South America, Middle East & Africa Peptide Therapeutics Market Size by Application (2027-2032) & (US$ Million) Table 130. South America, Middle East & Africa Peptide Therapeutics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 131. South America, Middle East & Africa Peptide Therapeutics Market Size by Country (2021-2026) Table 132. South America, Middle East & Africa Peptide Therapeutics Market Size by Country (2027-2032) Table 133. Research Programs/Design for This Report Table 134. Authors List of This Report Table 135. Secondary Sources Table 136. Primary Sources List of Figures Figure 1. Peptide Therapeutics Product Image Figure 2. Global Peptide Therapeutics Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Peptide Therapeutics Market Share by Type: 2025 VS 2032 Figure 4. Injection Image Figure 5. Oral Image Figure 6. Other Image Figure 7. Global Peptide Therapeutics Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Peptide Therapeutics Market Share by Application: 2025 VS 2032 Figure 9. Cancer Image Figure 10. Metabolic Disorders Image Figure 11. Central Nervous System Image Figure 12. Other Image Figure 13. Global Peptide Therapeutics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Peptide Therapeutics Market Size (2021-2032) & (US$ Million) Figure 15. Global Peptide Therapeutics Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global Peptide Therapeutics Market Share by Players in 2025 Figure 18. Global Top 5 and 10 Peptide Therapeutics Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Peptide Therapeutics Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Peptide Therapeutics Revenue Market Share by Type (2021-2032) Figure 22. Global Peptide Therapeutics Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Peptide Therapeutics Revenue Market Share by Application (2021-2032) Figure 24. North America Peptide Therapeutics Market Size (2021-2032) & (US$ Million) Figure 25. North America Peptide Therapeutics Market Share by Type (2021-2032) Figure 26. North America Peptide Therapeutics Market Share by Application (2021-2032) Figure 27. North America Peptide Therapeutics Market Share by Country (2021-2032) Figure 28. United States Peptide Therapeutics Market Size (2021-2032) & (US$ Million) Figure 29. Canada Peptide Therapeutics Market Size (2021-2032) & (US$ Million) Figure 30. Mexico Peptide Therapeutics Market Size (2021-2032) & (US$ Million) Figure 31. Europe Peptide Therapeutics Market Size (2021-2032) & (US$ Million) Figure 32. Europe Peptide Therapeutics Market Share by Type (2021-2032) Figure 33. Europe Peptide Therapeutics Market Share by Application (2021-2032) Figure 34. Europe Peptide Therapeutics Market Share by Country (2021-2032) Figure 35. Germany Peptide Therapeutics Market Size (2021-2032) & (US$ Million) Figure 36. France Peptide Therapeutics Market Size (2021-2032) & (US$ Million) Figure 37. U.K. Peptide Therapeutics Market Size (2021-2032) & (US$ Million) Figure 38. Italy Peptide Therapeutics Market Size (2021-2032) & (US$ Million) Figure 39. Russia Peptide Therapeutics Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries Peptide Therapeutics Market Size (2021-2032) & (US$ Million) Figure 41. China Peptide Therapeutics Market Size (2021-2032) & (US$ Million) Figure 42. China Peptide Therapeutics Market Share by Type (2021-2032) Figure 43. China Peptide Therapeutics Market Share by Application (2021-2032) Figure 44. Asia Peptide Therapeutics Market Size (2021-2032) & (US$ Million) Figure 45. Asia Peptide Therapeutics Market Share by Type (2021-2032) Figure 46. Asia Peptide Therapeutics Market Share by Application (2021-2032) Figure 47. Asia Peptide Therapeutics Market Share by Country (2021-2032) Figure 48. Japan Peptide Therapeutics Market Size (2021-2032) & (US$ Million) Figure 49. South Korea Peptide Therapeutics Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan Peptide Therapeutics Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia Peptide Therapeutics Market Size (2021-2032) & (US$ Million) Figure 52. India Peptide Therapeutics Market Size (2021-2032) & (US$ Million) Figure 53. Australia Peptide Therapeutics Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Peptide Therapeutics Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Peptide Therapeutics Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa Peptide Therapeutics Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa Peptide Therapeutics Market Share by Country (2021-2032) Figure 58. Brazil Peptide Therapeutics Market Size (2021-2032) & (US$ Million) Figure 59. South Africa Peptide Therapeutics Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Peptide Therapeutics Market Size (2021-2032) & (US$ Million) Figure 61. Turkey Peptide Therapeutics Market Size (2021-2032) & (US$ Million) Figure 62. Argentina Peptide Therapeutics Market Size (2021-2032) & (US$ Million) Figure 63. UAE Peptide Therapeutics Market Size (2021-2032) & (US$ Million) Figure 64. Egypt Peptide Therapeutics Market Size (2021-2032) & (US$ Million) Figure 65. Chile Peptide Therapeutics Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Injection
  • Oral
  • Other
Applications
  • Cancer
  • Metabolic Disorders
  • Central Nervous System
  • Other
Companies covered
  • Sanofi
  • Teva
  • Novo Nordisk
  • Takeda
  • Eli Lilly
  • AstraZeneca
  • Novartis
  • AbbVie
  • Ipsen
  • Ferring
  • Merck
  • The Medicines
  • J & J

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Peptide Therapeutics Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Injection
  5. 1.2.3 Oral
  6. 1.2.4 Other
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Peptide Therapeutics Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Cancer
  10. 1.3.3 Metabolic Disorders
  11. 1.3.4 Central Nervous System
  12. 1.3.5 Other
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global Peptide Therapeutics Growth Trends by Region
  15. 1.5.1 Global Peptide Therapeutics Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 Peptide Therapeutics Market Size by Region (2021-2026)
  17. 1.5.3 Peptide Therapeutics Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global Peptide Therapeutics Market Dynamics
  1. 2.1 Peptide Therapeutics Industry Trends
  2. 2.2 Peptide Therapeutics Industry Drivers
  3. 2.3 Peptide Therapeutics Industry Opportunities and Challenges
  4. 2.4 Peptide Therapeutics Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Peptide Therapeutics Revenue by Company (2021-2026)
  2. 3.2 Global Peptide Therapeutics Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Peptide Therapeutics Key Company Head office and Area Served
  4. 3.4 Global Peptide Therapeutics Company, Product Type & Application
  5. 3.5 Global Peptide Therapeutics Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Peptide Therapeutics Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Peptide Therapeutics Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Peptide Therapeutics Tier 1, Tier 2, and Tier 3
4 Peptide Therapeutics Market by Type
  1. 4.1 Global Peptide Therapeutics Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Peptide Therapeutics Market Size by Type (2021-2032)
  3. 4.3 Global Peptide Therapeutics Market Size Share by Type (2021-2032)
5 Peptide Therapeutics Market by Application
  1. 5.1 Global Peptide Therapeutics Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Peptide Therapeutics Market Size by Application (2021-2032)
  3. 5.3 Global Peptide Therapeutics Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Sanofi
  2. 6.1.1 Sanofi Company Information
  3. 6.1.2 Sanofi Business Overview
  4. 6.1.3 Sanofi Peptide Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Sanofi Peptide Therapeutics Product Portfolio
  6. 6.1.5 Sanofi Recent Developments
  7. 6.2 Teva
  8. 6.2.1 Teva Company Information
  9. 6.2.2 Teva Business Overview
  10. 6.2.3 Teva Peptide Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Teva Peptide Therapeutics Product Portfolio
  12. 6.2.5 Teva Recent Developments
  13. 6.3 Novo Nordisk
  14. 6.3.1 Novo Nordisk Company Information
  15. 6.3.2 Novo Nordisk Business Overview
  16. 6.3.3 Novo Nordisk Peptide Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Novo Nordisk Peptide Therapeutics Product Portfolio
  18. 6.3.5 Novo Nordisk Recent Developments
  19. 6.4 Takeda
  20. 6.4.1 Takeda Company Information
  21. 6.4.2 Takeda Business Overview
  22. 6.4.3 Takeda Peptide Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Takeda Peptide Therapeutics Product Portfolio
  24. 6.4.5 Takeda Recent Developments
  25. 6.5 Eli Lilly
  26. 6.5.1 Eli Lilly Company Information
  27. 6.5.2 Eli Lilly Business Overview
  28. 6.5.3 Eli Lilly Peptide Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Eli Lilly Peptide Therapeutics Product Portfolio
  30. 6.5.5 Eli Lilly Recent Developments
  31. 6.6 AstraZeneca
  32. 6.6.1 AstraZeneca Company Information
  33. 6.6.2 AstraZeneca Business Overview
  34. 6.6.3 AstraZeneca Peptide Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 AstraZeneca Peptide Therapeutics Product Portfolio
  36. 6.6.5 AstraZeneca Recent Developments
  37. 6.7 Novartis
  38. 6.7.1 Novartis Company Information
  39. 6.7.2 Novartis Business Overview
  40. 6.7.3 Novartis Peptide Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Novartis Peptide Therapeutics Product Portfolio
  42. 6.7.5 Novartis Recent Developments
  43. 6.8 AbbVie
  44. 6.8.1 AbbVie Company Information
  45. 6.8.2 AbbVie Business Overview
  46. 6.8.3 AbbVie Peptide Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 AbbVie Peptide Therapeutics Product Portfolio
  48. 6.8.5 AbbVie Recent Developments
  49. 6.9 Ipsen
  50. 6.9.1 Ipsen Company Information
  51. 6.9.2 Ipsen Business Overview
  52. 6.9.3 Ipsen Peptide Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Ipsen Peptide Therapeutics Product Portfolio
  54. 6.9.5 Ipsen Recent Developments
  55. 6.10 Ferring
  56. 6.10.1 Ferring Company Information
  57. 6.10.2 Ferring Business Overview
  58. 6.10.3 Ferring Peptide Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Ferring Peptide Therapeutics Product Portfolio
  60. 6.10.5 Ferring Recent Developments
  61. 6.11 Merck
  62. 6.11.1 Merck Company Information
  63. 6.11.2 Merck Business Overview
  64. 6.11.3 Merck Peptide Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Merck Peptide Therapeutics Product Portfolio
  66. 6.11.5 Merck Recent Developments
  67. 6.12 The Medicines
  68. 6.12.1 The Medicines Company Information
  69. 6.12.2 The Medicines Business Overview
  70. 6.12.3 The Medicines Peptide Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 The Medicines Peptide Therapeutics Product Portfolio
  72. 6.12.5 The Medicines Recent Developments
  73. 6.13 J & J
  74. 6.13.1 J & J Company Information
  75. 6.13.2 J & J Business Overview
  76. 6.13.3 J & J Peptide Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 J & J Peptide Therapeutics Product Portfolio
  78. 6.13.5 J & J Recent Developments
7 North America
  1. 7.1 North America Peptide Therapeutics Market Size (2021-2032)
  2. 7.2 North America Peptide Therapeutics Market Size by Type
  3. 7.2.1 North America Peptide Therapeutics Market Size by Type (2021-2026)
  4. 7.2.2 North America Peptide Therapeutics Market Size by Type (2027-2032)
  5. 7.2.3 North America Peptide Therapeutics Market Share by Type (2021-2032)
  6. 7.3 North America Peptide Therapeutics Market Size by Application
  7. 7.3.1 North America Peptide Therapeutics Market Size by Application (2021-2026)
  8. 7.3.2 North America Peptide Therapeutics Market Size by Application (2027-2032)
  9. 7.3.3 North America Peptide Therapeutics Market Share by Application (2021-2032)
  10. 7.4 North America Peptide Therapeutics Market Size by Country
  11. 7.4.1 North America Peptide Therapeutics Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Peptide Therapeutics Market Size by Country (2021-2026)
  13. 7.4.3 North America Peptide Therapeutics Market Size by Country (2027-2032)
  14. 7.4.4 North America Peptide Therapeutics Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Peptide Therapeutics Market Size (2021-2032)
  2. 8.2 Europe Peptide Therapeutics Market Size by Type
  3. 8.2.1 Europe Peptide Therapeutics Market Size by Type (2021-2026)
  4. 8.2.2 Europe Peptide Therapeutics Market Size by Type (2027-2032)
  5. 8.2.3 Europe Peptide Therapeutics Market Share by Type (2021-2032)
  6. 8.3 Europe Peptide Therapeutics Market Size by Application
  7. 8.3.1 Europe Peptide Therapeutics Market Size by Application (2021-2026)
  8. 8.3.2 Europe Peptide Therapeutics Market Size by Application (2027-2032)
  9. 8.3.3 Europe Peptide Therapeutics Market Share by Application (2021-2032)
  10. 8.4 Europe Peptide Therapeutics Market Size by Country
  11. 8.4.1 Europe Peptide Therapeutics Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Peptide Therapeutics Market Size by Country (2021-2026)
  13. 8.4.3 Europe Peptide Therapeutics Market Size by Country (2027-2032)
  14. 8.4.4 Europe Peptide Therapeutics Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Peptide Therapeutics Market Size (2021-2032)
  2. 9.2 China Peptide Therapeutics Market Size by Type
  3. 9.2.1 China Peptide Therapeutics Market Size by Type (2021-2026)
  4. 9.2.2 China Peptide Therapeutics Market Size by Type (2027-2032)
  5. 9.2.3 China Peptide Therapeutics Market Share by Type (2021-2032)
  6. 9.3 China Peptide Therapeutics Market Size by Application
  7. 9.3.1 China Peptide Therapeutics Market Size by Application (2021-2026)
  8. 9.3.2 China Peptide Therapeutics Market Size by Application (2027-2032)
  9. 9.3.3 China Peptide Therapeutics Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Peptide Therapeutics Market Size (2021-2032)
  2. 10.2 Asia Peptide Therapeutics Market Size by Type
  3. 10.2.1 Asia Peptide Therapeutics Market Size by Type (2021-2026)
  4. 10.2.2 Asia Peptide Therapeutics Market Size by Type (2027-2032)
  5. 10.2.3 Asia Peptide Therapeutics Market Share by Type (2021-2032)
  6. 10.3 Asia Peptide Therapeutics Market Size by Application
  7. 10.3.1 Asia Peptide Therapeutics Market Size by Application (2021-2026)
  8. 10.3.2 Asia Peptide Therapeutics Market Size by Application (2027-2032)
  9. 10.3.3 Asia Peptide Therapeutics Market Share by Application (2021-2032)
  10. 10.4 Asia Peptide Therapeutics Market Size by Country
  11. 10.4.1 Asia Peptide Therapeutics Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Peptide Therapeutics Market Size by Country (2021-2026)
  13. 10.4.3 Asia Peptide Therapeutics Market Size by Country (2027-2032)
  14. 10.4.4 Asia Peptide Therapeutics Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Peptide Therapeutics Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Peptide Therapeutics Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Peptide Therapeutics Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Peptide Therapeutics Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Peptide Therapeutics Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Peptide Therapeutics Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Peptide Therapeutics Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Peptide Therapeutics Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Peptide Therapeutics Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Peptide Therapeutics Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Peptide Therapeutics Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Peptide Therapeutics Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Peptide Therapeutics Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Peptide Therapeutics Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst